natgillin/translations-raw huggingface dataset:
Therefore, the CHMP’s view was that, as for Keppra, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da koristi nadmašuju utvrđeni rizik, kao i za lijek Keppra.
Therefore, the CHMP’s view was that, as for Keppra, the benefit outweighs the identified risk.
Stoga je stav Povjerenstva kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Keppra.
Therefore, the CHMP’s view was that, as for Lantus, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da u pogledu lijeka Lantus koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Lyrica, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da kao i u slučaju lijeka Lyrica koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Lyrica, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da kao i u slučaju lijeka Pregabalin Zentiva koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Lyrica, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i u slučaju lijeka Lyrica, koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Micardis, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Micardis.
Therefore, the CHMP’s view was that, as for Mimpara, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da u pogledu lijeka Mimpara koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Mirapexin, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da korist nadmašuje identificirani rizik, kao i za Mirapexin.
Therefore, the CHMP’s view was that, as for Neupogen, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao u slučaju lijeka Neupogen, koristi nadmašuju utvrđeni rizik.
Therefore, the CHMP’s view was that, as for Neupogen, the benefit outweighs the identified risk.
Stoga, CHMP je mišljenja da, kao i u slučaju lijeka Neupogen, koristi nadmašuju identificirani rizik.
Therefore, the CHMP’s view was that, as for Neupogen, the benefit outweighs the identified risks and recommended that it be approved for use in the EU.
Stoga je stav CHMP-a da u pogledu lijeka Neupogen koristi nadmašuju utvrđene rizike i preporučio je izdavanje odobrenja za stavljanje u promet lijeka u EU-u.
Therefore, the CHMP’s view was that, as for Neupogen, the benefit outweighs the identified risks.
Stoga je mišljenje CHMP-a da, kao u slučaju lijeka Neupogen, koristi nadmašuju identificirane rizike.
Therefore, the CHMP’s view was that, as for NovoNorm, the benefit outweighs the identified risk.
Stoga je stav CHMP- a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka NovoNorm.
Therefore, the CHMP’s view was that, as for other authorised forms of tacrolimus, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod drugih ovlaštenih oblika takrolimusa.
Therefore, the CHMP’s view was that, as for Plavix, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i u slučaju lijeka Plavix, koristi nadmašuju utvrđeni rizik.
Therefore, the CHMP’s view was that, as for Plavix, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao u slučaju lijeka Plavix, koristi nadmašuju utvrđeni rizik.
Therefore, the CHMP’s view was that, as for Plavix, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Plavix.
Therefore, the CHMP’s view was that, as for Plavix, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđeni rizik, kao i u slučaju lijeka Plavix.
Therefore, the CHMP’s view was that, as for reference medicine, the benefits of Nordimet outweighs it risks.
Stoga je stav CHMP-a da koristi nadmašuju utvrđene rizike, kao i za referentni lijek.
Therefore, the CHMP’s view was that, as for Remicade, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđeni rizik, kao i za lijek Remicade.
Therefore, the CHMP’s view was that, as for Remicade, the benefit outweighs the identified risks.
Stoga je stav CHMP-a da njegove koristi, kao i za lijek Remicade, nadmašuju s njim povezane rizike.
Therefore, the CHMP’s view was that, as for Seretide Diskus, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da korist nadmašuje identificirani rizik, kao i za lijek Seretide Diskus.
Therefore, the CHMP’s view was that, as for Sifrol, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Sifrol.
Therefore, the CHMP’s view was that, as for Symbicort Turbohaler, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi od lijeka Symbicort Turbohaler nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Symbicort Turbohaler, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi, kao i kod lijeka Symbicort Turbohaler, nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Symbicort Turbohaler, the benefit outweighs the identified risk.
Stoga je stav Povjerenstva kako koristi od lijeka Symbicort Turbohaler nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Tamiflu, the benefit outweighs the identified risks.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i u slučaju lijeka Tamiflu.
Therefore, the CHMP’s view was that, as for Taxotere, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Taxotere.
Therefore, the CHMP’s view was that, as for Temodal, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i kod lijeka Temodal, koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Temodal, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Temodal.
Therefore, the CHMP’s view was that, as for Temodal, the benefit outweighs the identified risk.
Stoga je stav Odbora kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Temodal.
Therefore, the CHMP’s view was that, as for Tractocile, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i kod lijeka Tractocile koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Velcade, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da korist nadmašuje identificirani rizik, kao i za lijek Velcade.
Therefore, the CHMP’s view was that, as for Velcade, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i kod lijeka Velcade, koristi nadmašuju utvrđeni rizik.
Therefore, the CHMP’s view was that, as for Vfend, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da u pogledu lijeka Vfend koristi nadmašuju identificirane rizike.
Therefore, the CHMP’s view was that, as for Vfend, the benefit outweighs the identified risks.
Stoga je stav CHMP-a da koristi nadmašuju utvrđene rizike, kao i kod lijeka Vfend.
Therefore, the CHMP’s view was that, as for Viagra, the benefit outweighs the identified risk.
Stoga je stav Odbora kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Viagra.
Therefore, the CHMP’s view was that, as for Viramune, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Viramune.
Therefore, the CHMP’s view was that, as for Xeloda, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i kod lijeka Xeloda, koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Zometa and Aclasta, the benefit outweighs the identified risks.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijekova Zometa i Aclasta.
Therefore, the CHMP’s view was that, as for Zometa, the benefit outweighs the identified risk.
Stoga je stav CHMP-a da, kao i kod lijeka Zometa, koristi nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Zometa, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Zometa.
Therefore, the CHMP’s view was that, as for Zometa, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđeni rizik, kao i kod lijeka Zometa.
Therefore, the CHMP’s view was that, as for Zonegran, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi nadmašuju utvrđeni rizik, kao i kod lijeka Zonegran.
Therefore, the CHMP’s view was that, as for Zyprexa and Zyprexa Velotab, the benefit outweighs the identified risk.
Stoga je stav CHMP-a kako koristi lijekova Zyprexa i Zyprexa Velotab nadmašuju utvrđene rizike.
Therefore, the CHMP’s view was that, as for Zyprexa and Zyprexa Velotab, the benefit outweighs the identified risk.
Stoga je stav Odbora kako koristi nadmašuju utvrđene rizike, kao i kod Zyprexa i Zyprexa Velotab.
Therefore, the CHMP’s view was that, as for Zyprexa, the benefit outweighs the identified risk.
Stoga je stav Odbora kako koristi nadmašuju utvrđene rizike, kao i kod Zyprexa.
Therefore, the CHMP’s view was that, as for Zyprexa, the benefit outweighs the identified risk.
Stoga je stav Povjerenstva kako koristi nadmašuju utvrđene rizike, kao i kod Zyprexa.
Therefore, the co-administration of tipranavir, co-administered with low dose ritonavir, with protease inhibitors is not recommended.
Stoga se ne preporuča istodobna primjena tipranavira s niskom dozom ritonavira i inhibitora proteaze.
Therefore, the combination of adalimumab and anakinra is not recommended. (See section 4.5).
Stoga se istodobna primjena adalimumaba i anakinre ne preporučuje (vidjeti dio 4.5).
Therefore, the combination of Inflectra and anakinra is not recommended.
Stoga se ne preporučuje kombinirana primjena lijeka Inflectra i anakinre.
Therefore, the combination of lithium and Irbesartan/Hydrochlorothiazide Teva is not recommended (see section 4.4).
Stoga se kombinacija litija i lijeka Irbesartan/Hidroklorotiazid Teva ne preporučuje (vidjeti dio 4.4.).
Therefore, the combination of Oncaspar with oral contraception is not recommended.
Stoga se ne preporučuje kombinacija Oncaspara s oralnom kontracepcijom.
Therefore, the combination of Remsima and anakinra is not recommended.
Stoga se ne preporučuje kombinirana primjena lijeka Remsima i anakinre.
Therefore, the Committee decided that Atriance’s benefits are greater than its risks and recommended that it be given marketing authorisation.
CHMP je odlučio da koristi od lijeka Atriance nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
Therefore, the company withdrew its application for the use of Abraxane as first- line treatment during the assessment of the medicine.
Stoga je tvrtka povukla svoj zahtjev za primjenu lijeka Abraxane u primarnoj terapiji tijekom procjene lijeka.
Therefore, the concomitant use of bortezomib with strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin, phenobarbital and St. John’s Wort) is not recommended, as efficacy may be reduced.
Stoga se ne preporučuje istodobna primjena bortezomiba i jakih induktora enzima CYP3A4 (npr. rifampicina, karbamazepina, fenitoina, fenobarbitala i Gospine trave), jer djelotvornost može biti smanjena.
Therefore, the concomitant use of ondansetron with vandetanib is not-recommended.
Stoga se istodobna primjena ondanzetrona i vandetaniba ne preporučuje.
Therefore, the concomitant use of strong CYP3A inhibitors (certain protease inhibitors like atazanavir, indinavir, nelfinavir, ritonavir, saquinavir, and certain azole antifungals like itraconazole, ketoconazole, and voriconazole, certain macrolides like clarithromycin, telithromycin, and troleandomycin) should be avoided.
Stoga treba izbjegavati istodobnu primjenu snažnih inhibitora CYP3A (nekih inhibitora proteaze poput atazanavira, indinavira, nelfinavira, ritonavira i sakvinavira, nekih azolnih antimikotika poput itrakonazola, ketokonazola i vorikonazola i nekih makrolida poput klaritromicina, telitromicina i troleandomicina).
Therefore, the concomitant use of trabectedin with strong CYP3A4 inducers (e.g., rifampicin, phenobarbital, Saint John’s Wort) should be avoided if possible (see section 4.4).
Stoga, istodobnu primjenu trabektedina sa snažnim CYP3A4 induktorima (npr . rifampicin, fenobarbital, gospina trava) treba izbjegavati ako je to moguće (vidjeti dio 4.4).
Therefore, the concomitant use of zidovudine or abacavir with Aptivus, co-administered with low dose ritonavir, is not-recommended unless there are no other available NRTIs suitable for patient management (see section 4.5).
Stoga se istodobna primjena zidovudina ili abakavira s Aptivusom uz nisku dozu ritonavira, ne preporučuje, osim ako su oni jedini NRTI prikladni za zbrinjavanje bolesnika (vidjeti dio 4.5).
Therefore, the CVMP’s view was that, as for Dexdomitor, the benefits outweigh the identified risks.
Stoga je stav CVMP-a da u slučaju VMP-a Dexdomitor koristi nadmašuju utvrđene rizike.
Therefore, the CVMP’s view was that, as for Metacam, Melovem’s benefits are greater than its risks for the approved indications and the Committee recommended that Melovem be given a marketing authorisation.
Stajalište CVMP-a, baš kao i u slučaju Metacama, bilo je da su koristi Melovema veće od njegovih rizika za odobrene indikacije i Povjerenstvo je preporučilo izdavanje odobrenja za stavljanje u promet za Melovem.
Therefore, the CVMP’s view was that, as for Metacam, the benefits outweigh the identified risks.
Stoga je stav CVMP-a da u slučaju VMP-a Metacam koristi nadmašuju utvrđene rizike.
Therefore, the CVMP’s view was that, as for SevoFlo, the benefits outweigh the identified risks.
Stoga je stav CVMP-a da u slučaju VMP-a SevoFlo koristi nadmašuju utvrđene rizike.
Therefore, the daily exposure to 5-FU would be expected to be comparable in these groups, since the daily exposure in patients in the severe renal impairment group is based on the administration of Teysuno once a day, while the daily exposure to 5-FU in the patients with normal renal function is based on the administration of Teysuno twice daily.
Za očekivati je usporedivost dnevne izloženosti 5- FU-u u tim skupinama jer je dnevna izloženost u skupini s teškim oštećenjem bubrega bazirana na primjeni lijeka Teysuno jednom dnevno, dok je dnevna izloženost 5-FU-u u bolesnika s normalnom funkcijom bubrega bazirana na primjeni lijeka Teysuno dva puta na dan.
Therefore, the daily exposure to 5-FU would be expected to be comparable in these groups, since the daily exposure in patients in the severe renal impairment group is based on the administration of Teysuno once a day, while the daily exposure to 5-FU in the patients with normal renal function is based on the administration of Teysuno twice daily.
Za očekivati je usporedivost dnevne izloženosti 5- FU-u u tim skupinama, jer je dnevna izloženost u skupini sa teškim oštećenjem bubrega bazirana na primjeni lijeka Teysuno jednom dnevno, dok je dnevna izloženost 5-FU-u u bolesnika sa normalnom funkcijom bubrega bazirana na primjeni lijeka Teysuno dva puta na dan.
Therefore, the data that have been generated with AS03- adjuvanted vaccine containing 3.75 µg HA derived from A/Vietnam/1194/2004 are considered to be relevant to the use of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005.
Stoga se podaci dobiveni s AS03-adjuvantiranim cjepivom koje sadrži 3,75 µg hemaglutinina dobivenog iz soja A/Vietnam/1194/2004 smatraju značajnim za korištenje AS03-adjuvantiranog cjepiva koje sadrži 3,75 µg hemaglutinina dobivenog iz soja A/Indonesia/05/2005.
Therefore, the effect of vasopressin analogues such as desmopressin may be attenuated in patients using such analogues to prevent or control bleeding when co-administered with tolvaptan.
Prema tome, učinak vazopresinskih analoga, kao što je dezmopresin može biti smanjen kod bolesnika koji koriste takve analoge za sprječavanje ili kontroliranje krvarenja ako se daju istovremeno s tolvaptanom.
Therefore, the effectiveness observed in adults is also expected in children.
Stoga se djelotvornost uočena u odraslih osoba može očekivati i u djece.
Therefore, the following should always be adhered to:
Stoga se uvijek treba pridržavati sljedećih smjernica:
Therefore, the interaction of Matever with other substances, or vice versa, is unlikely.
Iz toga proizlazi da interakcija Matevera s drugim tvarima, i obrnuto, nije vjerojatna.
Therefore, the lack of significant colour change should not be taken as an assurance of adequate hydration.
Stoga se izostanak značajne promjene boje ne smije uzeti kao sigurni pokazatelj odgovarajuće vlažnosti.
Therefore, the long-term safety of chronic administration of Plegridy to patients cannot be assessed on the basis of these studies.
Stoga, dugotrajna sigurnost kronične primjene Plegridyja u bolesnika se ne može procijeniti na temelju tih istraživanja.
Therefore, the MAH's proposal to include this ADR in the product information is endorsed.
Stoga se podržava prijedlog nositelja odobrenja za stavljanje lijeka u promet da se ova nuspojava lijeka uključi u informacije o lijeku.
Therefore, the MAH's proposal to include this safety information in the product information is agreed.
Stoga se prihvaća prijedlog nositelja odobrenja za stavljanje lijeka u promet da se ova informacija o sigurnosti uključi u informacije o lijeku.
Therefore, the MAHs should add the undesirable effect “Rhabdomyolysis” under the SOC Musculoskeletal and connective tissue disorders (frequency ‘rare’) in the Product Information of all levetiracetam-containing products.
Stoga nositelji odobrenja trebaju dodati u informacije o lijeku nuspojavu “rabdomioliza” sukladno klasifikaciji organskih sustava pod poremećaje mišićno-koštanog sustava i vezivnog tkiva (učestalost ‘rijetko’) za sve lijekove koji sadrže levetiracetam.
Therefore, the Orkambi dose should be reduced to two tablets in the morning and one tablet in the evening (lumacaftor 600 mg/ivacaftor 375 mg total daily dose) for patients with moderate hepatic impairment (Child-Pugh Class B).
Stoga, u bolesnika s umjerenim oštećenjem funkcije jetre (Child-Pugh stadij B), dozu lijeka Orkambi treba smanjiti na dvije tablete ujutro i jednu tabletu navečer (ukupna dnevna doza je 600 mg lumakaftora/375 mg ivakaftora).
Therefore, the patient must be instructed that the priming should be conducted in a well ventilated area, pointing away from the patient and other people, and away from surfaces and objects that could come into contact with other people, particularly children.
Stoga se bolesnika mora uputiti da pripremu spreja treba provesti u dobro prozračenom prostoru raspršujući lijek u smjeru suprotnom od bolesnika i drugih osoba i podalje od površina i predmeta koji bi mogli doći u doticaj s drugim osobama posebice djecom.
Therefore, the pharmacokinetic parameter estimates shown in the table account for reductions in the pharmacokinetic parameters of etravirine due to co-administration of INTELENCE with darunavir/ritonavir.
Stoga, procjene farmakokinetičkih parametara koje su prikazane u tablici uzimaju u obzir smanjenje farmakokinetičkih prametara etravirina radi istodobne primjene INTELENCEa s darunavirom/ritonavirom.
Therefore, the possibility of decreased efficacy of progestative- containing oral contraceptives should be considered for women needing Fycompa 12 mg/day and an additional reliable method (intra-uterine device (IUD), condom) is to be used (see section 4.4).
Stoga se u žena kojima je potrebna Fycompa u dozi od 12 mg na dan mora uzeti u obzir mogućnost smanjene djelotvornosti oralnih kontraceptiva koji sadrže progestagene i primjena dodatne pouzdane metode kontracepcije (intrauterini uložak, kondom) (vidjeti dio 4.4).
Therefore, the PRAC agreed that that ‘Asthma’ should be added in section 4.8 for Ganfort and Ganfort PF and ‘Dyspnoea’ in section 4.8 for Ganfort PF.
Stoga je PRAC suglasan da je potrebno dodati „Astmu" u dijelu 4.8 za Ganfort i Ganfort bez konzervansa, te „Dispneju" u dio 4.8 za Ganfort bez konzervansa.
Therefore, the PRAC agreed that ‘Alopecia’ should be added in section 4.8 for Ganfort.
Stoga je PRAC suglasan da je potrebno dodati „Alopeciju" u dijelu 4.8 za Ganfort.
Therefore, the PRAC agreed that ‘Bradycardia’ should be added in section 4.8 for both Ganfort and Ganfort PF.
Stoga je PRAC suglasan da je potrebno dodati „Bradikardiju" u dijelu 4.8 kako za Ganfort tako i za Ganfort bez konzervansa.
Therefore, the PRAC agreed that ‘Dysgeusia’ should be added in section 4.8 for Ganfort.
Stoga je PRAC suglasan da je potrebno dodati „Disgeuziju" u dijelu 4.8 za Ganfort.
Therefore, the PRAC agreed that ‘Eye swelling’ should be added in section 4.8 for both Ganfort and Ganfort PF.
Stoga je PRAC suglasan da je potrebno dodati „Oticanje oka" u dijelu 4.8 kako za Ganfort tako i za Ganfort bez konzervansa.
Therefore, the PRAC agreed that ‘Fatigue’ should be added in section 4.8 for Ganfort.
Stoga je PRAC suglasan da je potrebno dodati „Umor" u dijelu 4.8 za Ganfort.
Therefore, the PRAC agreed that ‘Nightmare and Insomnia’ should be added in section 4.8 for Ganfort.
Stoga je PRAC suglasan da je potrebno dodati „Noćnu moru i nesanicu" u dijelu 4.8 za Ganfort.
Therefore, the PRAC agreed that ‘Vision blurred’ should be added in section 4.8 for Ganfort.
Stoga je PRAC suglasan da je potrebno dodati „Zamućen vid" u dijelu 4.8 za Ganfort.
Therefore, the product is suitable to be used in eradication programmes against Aujeszky’s disease field virus in pigs based on the presence or absence of antibodies against the gE-antigen of that virus.
Stoga je proizvod pogodan za primjenu u programima iskorjenjivanja terenskog virusa bolesti Aujeszkoga kod svinja na temelju prisutnosti ili odsutnosti protutijela protiv gE-antigena tog virusa.
Therefore, the product should be administered at regular monthly intervals during the time of the year when mosquitoes are present, starting in the month after the first expected exposure to them.
Stoga se proizvod treba primijeniti u redovitim mjesečnim intervalima tijekom dijela godine kad su komarci prisutni, s početkom u mjesecu nakon prvog mogućeg izlaganja komarcima.
Therefore, the product should be administered to pregnant and lactating women only if clearly needed.
Stoga se ovaj lijek smije primijeniti u trudnica i dojilja samo ako je to uistinu nužno.
Therefore, the product should be used with caution with other veterinary medicinal products which induce, inhibit, or which are metabolised by these enzymes.
Stoga lijek treba koristiti s oprezom s drugim veterinarsko-medicinskim proizvodima koji induciraju ili inhibiraju CYP 450 ili koji su metabolizirani ovim enzimima.
Therefore, the product should not be administered with antimicrobials with a similar mode of action such as other macrolides or lincosamides.
Ne primjenjivati s drugim antimikrobnim VMP sa sličnim načinom djelovanja kao što su makrolidi ili linkozamidi.
Therefore, the pump must be prepared (primed) by pushing the dosing pump head down completely five times in succession (fig.
Stoga se pumpica mora pripremiti potpunim pritiskom na vrh pumpice za doziranje prema dolje pet puta zaredom (sl.
Therefore, the pump must be prepared (primed) by pushing the dosing pump head down completely five times in succession (fig.
Stoga se pumpica mora pripremiti potpunim pritiskom prema dolje na vrh pumpice za doziranje, pet puta zaredom (sl.
Therefore, the pump must be prepared (primed) by pushing the dosing pump head down completely five times in succession (fig.
Stoga se pumpica mora pripremiti potpunim pritiskom vrha pumpice za doziranje prema dolje, pet puta zaredom (sl.
Therefore, the removal of waste nitrogen also occurs evenly and this results in a better control of blood ammonia levels throughout the day.
Stoga se i uklanjanje otpadnog dušika odvija ravnomjerno što dovodi do boljeg nadzora razina amonijaka u krvi tijekom dana.
Therefore, the risk of metabolic drug-drug interactions due to oclacitinib inhibition is very low.
Zbog toga je rizik metaboličke interakcije lijeka sa lijekom radi inhibicije oclacitiniba vrlo nizak.
Therefore, the safety profile of Toujeo has not been established.
Stoga, sigurnosni profil lijeka Toujeo u toj populaciji nije ustanovljen.